Pagina 14 - I migliori medici di Ecografia - TOP-504medici

Professional experience

2007. Director of the Assisted Reproduction Unit of the Quironsalud University Hospital of Madrid since its opening.

2004-06 Private consultation on assisted reproduction in Madrid.

1994-96. Deputy Physician. Department of Gynecology and Obstetrics. Hospital 12 de Octubre, Madrid.

Membership in scientific societies

-He is a member of the Spanish Society of Gynecology and Obstetrics (SEGO).

-Spanish Society of Fertility (SEF);

-European Society of Human Reproduction (ESHRE)

-American Society for Reproductive Medicine (ASRM).

Research and Teaching

In recent years, he has conducted over 30 conferences, 20 presentations and 15 talks at courses and conferences in his specialty. He has written 5 book chapters and coordinated 4 monographs.

2010 Associate Professor. European University of Madrid.

2004-07 Professor of Master in Human Reproduction. Spanish Fertility Society and Complutense University.

1990-98 Professor, PhD student. Training Center for Medical Specialists (CTO)

Dr. Alper Karaoglan is a Professor of Neurosurgery at Memorial Bodrum Hospital. He has many years of experience in neurosurgery. He worked at Maltepe University Faculty of Medicine and Taksim Training and Research Hospital in Istanbul. Since 2008, he has held the positions of Professor, Associate Professor, and Assistant Professor in neurosurgery.

Dr. Karaoglan is a member of the Turkish Medical Association and the Turkish Neurosurgical Society. He has received several awards. These include the Best Paper Award at the Turkish Neurosurgical Society Scientific Congress in 2005 for his research on resveratrol’s protective effects after subarachnoid hemorrhage, and the Young Neurosurgeon Encouragement Award in 2008.

Education

Major degree in Medicine and Surgery (MBBS) Medical School University of Perugia, Italy. (2000-2006)

Internship at the Department of Cardiac Surgery, “S. Maria della Misericordia” University Hospital, Perugia, Italy. (2005 – 2006)

Clinical registration for Medicine and Surgery, “S. Maria della Misericordia” University Hospital, Perugia, Italy. (2006 – 2007)

Completion of the Italian Board Exams for the Medical and Surgical profession (Esame di Stato). Marks 262.5 / 270. Medical School University of Perugia, Italy. (June 2007)

Certificate of Completion of Training (CCT) in Cardiac Surgery. Marks 50/50. Thesis: “Trans-catheter Aortic Valve Implantation (TAVI) – A single centre experience”. Department of Cardio-thoracic Surgery “San Matteo” University Hospital, Pavia, Italy. (July 2014)

Training and Professional Experience

Junior Clinical Fellow in Cardiac Surgery, Department of Cardiac Surgery, “S. Maria della Misericordia” University Hospital, Perugia, Italy. (2007 – 2008)

Clinical Fellow in Cardiac Surgery, Department of Cardiac Surgery, “S. Maria della Misericordia” University Hospital, Perugia, Italy. (2008 – 2009)

Resident in Cardiac Surgery (CTh), Department of Cardio-thoracic Surgery, “San Matteo” University Hospital, Pavia, Italy. (2009 – 2014)

Cardiac Surgery Trainees Representative and Member of the Board of the School of Cardiac Surgery. “San Matteo” University Hospital, Pavia, Italy. (2011 – 2014)

Fellowship in Heart Transplant, Department of Cardio-thoracic Surgery “San Matteo” University Hospital, Pavia, Italy. (2011 – 2012)

Fellowship in Trans-catheter Aortic Valve Implantation (TAVI), Department of Cardio-thoracic Surgery “San Matteo” University Hospital, Pavia, Italy. (2013 – 2014)

Chief Resident in Cardiac Surgery, Department of Cardio-thoracic Surgery, “San Matteo” University Hospital, Pavia, Italy. (2013 – 2014)

Fellowship in Adult Cardiac Surgery, Department of Cardio-thoracic Surgery, St. Georges University Hospital, London, UK. (2014 – 2015)

Senior Specialty doctor in Cardiac Surgery, Department of Cardio-thoracic Surgery, Hull and East Yorkshire University Hospital, Hull, UK. (2015 – 2022)

Lead of Trust Appointed Doctors to the SCTS for the Cardio-thoracic Unit, Department of Cardio-thoracic Surgery, Hull and East Yorkshire University Hospital, Hull, UK. (2020 – 2022)

Director of the Cardiac Surgery Unit, German Medical Institute, Limassol, Cyprus. (2022 – present)

Scientific Activity

MD: Thesis: “The importance of the surgical timing on post-operative outcome in patients with acute endocarditis of native valve”. Medical School University of Perugia, Italy. (April 2005 – December 2006)

Collaborator at the multi-centre National project “Effects of Covid-19 Pandemic on the Provision of Cardiac Surgery in the UK”. Department of Cardio-thoracic Surgery, Hull and East Yorkshire University Hospital, Hull, UK. (2020 – 2022)

Co-investigator at the COMICs multi-centre International Randomised Controlled Trial (RCT) comparing Mini-Bypass (MIECC) with conventional bypass. Department of Cardio-thoracic Surgery, Hull and East Yorkshire University Hospital, Hull, UK. (2018 – 2022)

Co-investigator at the ROUTE multi-centre international registry, aimed to analyse the effectiveness and safety of Transaortic (TAo)-TAVI as a first line approach and to compare it to patients receiving TAo-TAVI as a last resort, which is current practice. Department of Cardio-thoracic Surgery, “San Matteo” University Hospital, Pavia, Italy. (2013 – 2014)

Special Interest

Myocardial revascularisation (coronary by-pass surgery with MIECC)

Aortic surgery (thoracic aorta aneurysm repair)

Aortic valve replacement or repair (minimal invasive, TAVI)

Mitral valve surgery (replacement or repair)

Heart transplant

Memberships

Founder member of the Cypriot Society of Cardiothoracic surgeons (CSCTS)  founded in 2023.

Member of the European Association for Cardiothoracic Surgery (EACTS)

Member of the Society for Cardiothoracic Surgery (SCTS) in Great Britain and Ireland

Registration at the Cypriot Ministry of Health as Specialist in Cardiac Surgery (2016)

GMC-UK Specialist Register: Cardiothoracic Surgery (2014)

Italian Medical Council (Ordine dei Medici-Chirurghi): Full Registration with Licence to practise (2008 – 2014)

Con 41 anni di esperienza, il medico è un urologo altamente qualificato in Germania. Si è laureato presso l'Università Johannes Gutenberg di Magonza e ha completato il suo dottorato in nefrologia nel 1980. Dal 1994, è docente presso l'Università Goethe di Francoforte sul Meno. Il suo focus clinico include l'oncologia urologica, il trattamento minimamente invasivo del cancro alla prostata, operazioni di tumori renali che preservano l'organo e l'urologia ricostruttiva. Il medico ha scritto oltre 100 articoli scientifici, contribuendo in modo significativo al campo dell'urologia.<\/p>

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Il medico ha completato gli studi di medicina presso l'Università di Vienna nel 1998, con formazione presso UCLA e l'Università della Pennsylvania. Dal 2000 al 2006, il medico si è formato come specialista in medicina interna presso l'Ospedale Generale di Vienna, seguito da una specializzazione aggiuntiva in gastroenterologia ed epatologia dal 2006 al 2008, e in medicina intensiva interna dal 2008 al 2010.<\/p>

Nel 2003, il medico ha fondato e gestito il laboratorio di emodinamica epatica e la clinica ambulatoriale per la cirrosi presso l'Università Medica di Vienna. Dal 2018, il medico è a capo del Dipartimento di Medicina Interna I presso l'Ospedale dei Fratelli della Misericordia di Vienna.<\/p>

Il medico è specialista in chirurgia generale e viscerale, operando come chirurgo presso il Dipartimento di Chirurgia Generale dell'Università Medica di Vienna. Guidando il team di chirurgia gastrica ed esofagea, il medico è anche il Capo dell'Unità Tumori Gastroesofagei presso il Centro Oncologico Comprensivo di Vienna.<\/p>

Con oltre 240 articoli specializzati pubblicati, il medico ha ricoperto ruoli significativi come Segretario Generale della Società Austriaca di Oncologia Chirurgica dal 2014 e Capo del Servizio GI Superiore dal 2012. Il medico è Professore Associato di Chirurgia ed è specialista in chirurgia GI superiore dal 2007.<\/p>

Professor Marek Ehrlich is a cardiac surgeon at University Hospital Vienna. He has led the hospital’s aneurysm program since 2010. He graduated from the Medical University of Vienna and specializes in cardiac surgery. He has also trained internationally at Stanford, Birmingham, Houston, and Mount Sinai Hospital in New York.

Dr. Ehrlich has published over 100 scientific articles on aneurysm surgery. He has led research in neuroprotection and endovascular techniques. He has received several international awards for his work. Dr. Ehrlich often speaks at major global conferences. He is fluent in English and Polish.

Prof. Gil Raviv, MD, PhD, is Director of the Andrology Unit at Sheba Medical Center. He was listed among the Best Doctors in Israel by Forbes in 2024. He is a leading expert in male fertility, sexual medicine, and reconstructive urology.

His primary focus is male infertility and fertility preservation. He performs advanced semen analysis according to WHO standards. He carries out testicular sperm retrieval (TESE, TESA, MESA) and semen cryopreservation. He also provides comprehensive fertility diagnostics with histological analysis.

He is a Professor at Tel Aviv University. He trained in Siena, Rome, and Tel Aviv. He completed a fellowship in infertility and impotence at Erasme Hospital. He received advanced training in reconstructive urethral surgery in Ghent. He is a member of the European Association of Urology, the International Society for Sexual Medicine, and the Israeli Urological Association.

Il medico è un oncochirurgo con 25 anni di esperienza, specializzato nel trattamento del cancro del retto e del colon, chirurgia bariatrica e trattamento del cancro esofageo.<\/p>

Con oltre 15.000 procedure chirurgiche eseguite, il medico esegue più di 1.000 interventi chirurgici minimamente invasivi all'anno, utilizzando tecniche laparoscopiche e robotiche.<\/p>

Membro di società mediche internazionali, il medico è presidente dell'Associazione dei Chirurghi-Endoscopisti in Europa e tiene conferenze sulle tecniche chirurgiche avanzate e la laparoscopia.<\/p>

Riconosciuto come pioniere nella chirurgia gastrointestinale, il medico è stato il primo a eseguire procedure rivoluzionarie come la rimozione della cistifellea attraverso la bocca e la prima escissione totale del mesoretto transanale (TaTME).<\/p>

Il medico è un oncocirurgo esperto con vasta esperienza in urologia. Come capo del Dipartimento di Urologia Samsung, il medico ha guidato numerose procedure chirurgiche innovative e ha contribuito a significativi progressi nel campo. Il medico è riconosciuto per la sua competenza nelle tecniche minimamente invasive ed è stato determinante nello sviluppo di nuovi protocolli per il trattamento del cancro. Il medico è altamente stimato per il suo impegno nella cura dei pazienti e ha ricevuto numerosi riconoscimenti per i suoi contributi alla ricerca medica e all'educazione.<\/p>

Il medico è un ginecologo altamente qualificato con una specializzazione in oncoginecologia, fornendo cure esperte nella diagnosi e nel trattamento dei tumori ginecologici. Con una vasta esperienza in approcci sia chirurgici che non chirurgici, il medico è impegnato a migliorare la salute delle donne attraverso trattamenti innovativi e cure compassionevoli.<\/p>

Il medico è un oncoginecologo esperto con vasta esperienza nel trattamento dei tumori ginecologici. Specializzandosi in tecniche chirurgiche avanzate e piani di trattamento personalizzati, il medico ha contribuito significativamente a migliorare i risultati dei pazienti. Con numerose pubblicazioni su riviste peer-reviewed, il medico è riconosciuto per la sua esperienza in procedure minimamente invasive ed è stato relatore principale in conferenze internazionali.<\/p>

Il medico possiede la certificazione del consiglio in oncologia ginecologica ed è attivamente coinvolto nella ricerca clinica, concentrandosi su terapie innovative e metodi di rilevamento precoce. Il medico è affiliato a un'istituzione medica leader e collabora con team multidisciplinari per fornire cure complete.<\/p>

Il medico è un oncologo altamente esperto con un focus su trattamenti innovativi per il cancro e cure personalizzate per i pazienti. Con oltre 15 anni di esperienza nel campo, il medico ha contribuito significativamente ai progressi nella chemioterapia e nell'immunoterapia. Il medico è certificato dal consiglio e ha pubblicato numerosi articoli di ricerca su riviste mediche prestigiose. Il medico è anche attivamente coinvolto in studi clinici ed è stato relatore principale in diverse conferenze internazionali di oncologia.<\/p>

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Il medico è un gastroenterologo di punta specializzato nella gestione dei tumori del pancreas, delle vie biliari e della cistifellea. Con un'esperienza vasta, il medico lavora come specialista in gastroenterologia presso il Dipartimento di Gastroenterologia del Samsung Medical Center.<\/p>

Il medico ha completato la sua formazione medica presso il College of Medicine dell'Università di Hanyang in Corea del Sud, con ulteriore formazione presso la Stanford University School of Medicine negli Stati Uniti e il Kyoto Second Red Cross Hospital in Giappone. Il medico è anche un membro attivo della Korean Society of Gastrointestinal Endoscopy e della Korean Society of Gastroenterology.<\/p>

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Il medico è un gastroenterologo di spicco in Corea del Sud e in Asia, specializzato nella gestione dei tumori del pancreas, delle vie biliari e della cistifellea, nonché della pancreatite e dei calcoli biliari.<\/p>

Attualmente pratica presso il Samsung Medical Center, il medico ha una formazione educativa presso il Seoul National University College of Medicine e l'Università della California.<\/p>

Il medico è un membro attivo di diverse organizzazioni professionali, tra cui la Società Coreana di Endoscopia Gastrointestinale, la Società Coreana di Gastroenterologia e l'Associazione Coreana di Pancreatobiliare.<\/p>

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.